Therefore, we set out to identify genetic variation in FKBP5 by performing Next Generation resequencing of this gene in 60 tumor and normal DNA samples obtained from 43 pancreatic cancer patients treated with gemcitabine. This evidence concerns the gene FKBP5 and pancreatic neoplasm.